Fulgent Genetics raises FY24 EPS view to 33c from (30c), consensus (39c)
The Fly

Fulgent Genetics raises FY24 EPS view to 33c from (30c), consensus (39c)

Backs FY24 revenue view $280M, consensus $282.17M. Paul Kim, CFO, said, “We are pleased with our financial performance in the third quarter and our trajectory for the remainder of 2024, as we continue to grow core revenue and improve operations.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App